Resveratrol prevents β-cell dedifferentiation in nonhuman primates given a high-fat/high-sugar diet.
Resveratrol prevents β-cell dedifferentiation in nonhuman primates given a high-fat/high-sugar diet.
复制标题
作者:
Fiori JL;Shin YK;Kim W;Krzysik-Walker SM;González-Mariscal I;Carlson OD;Sanghvi M;Moaddel R;Farhang K;Gadkaree SK;Doyle ME;Pearson KJ;Mattison JA;de Cabo R;Egan JM
Eating a “Westernized” diet high in fat and sugar leads to weight gain and numerous health problems, including the development of type 2 diabetes mellitus (T2DM). Rodent studies have shown that resveratrol supplementation reduces blood glucose levels, preserves β-cells in islets of Langerhans, and improves insulin action. Although rodent models are helpful for understanding β-cell biology and certain aspects of T2DM pathology, they fail to reproduce the complexity of the human disease as well as that of nonhuman primates. Rhesus monkeys were fed a standard diet (SD), or a high-fat/high-sugar diet in combination with either placebo (HFS) or resveratrol (HFS+Resv) for 24 months, and pancreata were examined before overt dysglycemia occurred. Increased glucose-stimulated insulin secretion and insulin resistance occurred in both HFS and HFS+Resv diets compared with SD. Although islet size was unaffected, there was a significant decrease in β-cells and an increase in α-cells containing glucagon and glucagon-like peptide 1 with HFS diets. Islets from HFS+Resv monkeys were morphologically similar to SD. HFS diets also resulted in decreased expression of essential β-cell transcription factors forkhead box O1 (FOXO1), NKX6–1, NKX2–2, and PDX1, which did not occur with resveratrol supplementation. Similar changes were observed in human islets where the effects of resveratrol were mediated through Sirtuin 1. These findings have implications for the management of humans with insulin resistance, prediabetes, and diabetes.
登录
查看更多内容
影响因子:
158.5
作者:
Knowler, WC;Barrett-Connor, E;Nathan, DM
通讯作者:
Nathan, DM
影响因子:
3.7
作者:
Liu Z;Kim W;Chen Z;Shin YK;Carlson OD;Fiori JL;Xin L;Napora JK;Short R;Odetunde JO;Lao Q;Egan JM
通讯作者:
Egan JM
影响因子:
7.7
作者:
Bonner C;Bacon S;Concannon CG;Rizvi SR;Baquié M;Farrelly AM;Kilbride SM;Dussmann H;Ward MW;Boulanger CM;Wollheim CB;Graf R;Byrne MM;Prehn JH
通讯作者:
Prehn JH
DOI:
10.1111/j.1752-8062.2011.00298.x
发表时间:
2011-08
期刊:
Clinical and translational science
影响因子:
--
作者:
Bremer AA;Stanhope KL;Graham JL;Cummings BP;Wang W;Saville BR;Havel PJ
通讯作者:
Havel PJ
影响因子:
64.8
作者:
Baur, Joseph A.;Pearson, Kevin J.;Sinclair, David A.
通讯作者:
Sinclair, David A.